Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMD vs MRNA✓SelectedUSD · MRNAAMD vs MRNA performance historyLatest closeAs of-0.17%11/17
Stock and ETF performance explorer

AMD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+317.4%
MRNA return
+168.0%
Excess return
+149.3%
Maximum drawdown
-63.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.2%-3.9%+3.8%0.0%
7D-2.3%-17.6%+15.3%-1.3%
30D-4.8%-5.1%+0.3%-4.4%
3M-0.5%+220.8%-221.3%-9.0%
6M+18.7%+321.7%-303.0%+0.6%
YTD+135.1%+601.3%-466.2%+79.4%
1Y+109.3%+735.2%-625.9%+54.1%
3Y+317.4%+170.5%+146.8%+267.0%
All+317.4%+168.0%+149.3%+267.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling